MEIRAGTX UK LIMITED
MEIRAGTX UK LIMITED is a private limited company registered in the United Kingdom, under 09535413, incorporated on 10 April 2015. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 11 years. Registered office address: N1 7NQ London, the United Kingdom. Formerly known as KADMON GENE THERAPY LIMITED. Directors include ALEXANDRIA JOSEFINA FORBES and MR. RICHARD BRIAN GIROUX. Sole shareholder is MEIRAGTX LIMITED. Associated with 6 related entities, including MEIRAGTX OCULAR UK LIMITED, MEIRAGTX GENE REGULATION LIMITED, and MEIRAGTX NEURO UK LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
KADMON GENE THERAPY LIMITED
Registered Address
92 BRITANNIA WALK
N1 7NQ LONDON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (2)
| Date | Change | Details |
|---|---|---|
| 2026-04-17 | DIRECTOR ADDED | Alexandria Josefina Forbes (director) |
| 2026-04-14 | DIRECTOR ADDED | Richard Brian Giroux (director) |
Source Records (1)
| companieshouse | 09535413 | 2026-06-01 | open_in_new |